Covidien announced the launch of Permacol™ Biologic Implant, a biologic mesh for hernia repair. The implant joins Covidien’s line of products as a result of acquisition of Tissue Science Laboratories by the company. It will be available in the American and  European markets in 2009. Containing improved porcine collagen, Permacol™ Biologic Implant brings together the clinical benefits of a biologic and a synthetic’s intra-operative efficiency. The hydrated and ready-to-use product can be cut or shaped as required, providing a suitable soft tissue repair.